Uptake of Clinical Decision Support Systems Among Health Care Professionals in Six European Countries and the United States: Cross-Sectional Survey Within the I-CARE4OLD Project - Summary - MDSpire

Uptake of Clinical Decision Support Systems Among Health Care Professionals in Six European Countries and the United States: Cross-Sectional Survey Within the I-CARE4OLD Project

  • By

  • Collin JC Exmann

  • Anna-Maria Hiltunen

  • Ira Haavisto

  • Anna Salminen

  • Maikki Messo

  • Mikko Nuutinen

  • Mark Hoogendoorn

  • Wiebe Boorsma

  • Elizabeth P Howard

  • Vanja Pešić

  • Mor Alon

  • Federica Mammarella

  • Rosa Liperoti

  • Olena Švihnosová

  • Daniela Fialová

  • Natalia Drapała

  • Katarzyna Szczerbińska

  • Anja Declercq

  • Hein PJ van Hout

  • Johanna De Almeida Mello

  • June 11, 2026

  • 0 min

Share

Objective:

To describe and compare the use of clinical decision support tools and attitudes toward future CDSS development among healthcare professionals caring for older adults with complex chronic conditions (CCC).

Key Findings:
  • Healthcare professionals reported varying levels of current use and perceived benefits of CDSS, as indicated by survey responses.
Interpretation:

Remove this section.

Limitations:
  • The study's cross-sectional design limits the ability to infer causality.
  • Data collection was limited to a specific timeframe and may not capture long-term trends.
Conclusion:

Revise to reflect only the insights provided in the source without editorial interpretation.

Sources:

Original Source(s)

Uptake of Clinical Decision Support Systems Among Health Care Professionals in Six European Countries and the United States: Cross-Sectional Survey Within the I-CARE4OLD Project

  • by Collin JC Exmann, Anna-Maria Hiltunen, Ira Haavisto, Anna Salminen, Maikki Messo, Mikko Nuutinen, Mark Hoogendoorn, Wiebe Boorsma, Elizabeth P Howard, Vanja Pešić, Mor Alon, Federica Mammarella, Rosa Liperoti, Olena Švihnosová, Daniela Fialová, Natalia Drapała, Katarzyna Szczerbińska, Anja Declercq, Hein PJ van Hout, Johanna De Almeida Mello

  • June 11, 2026

Related Content

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.

Smartphone-based abdominal inclination angles for assessing abdominal obesity: Convergent validity and reliability study

A multi-method study on GPs’ perspectives on Lipoprotein(a) as an actionable cardiovascular risk factor